Hunan Jingfeng Pharmaceutical Co.,Ltd.

000908

CNE000000Y11

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
1.39 ^CNY	-4.79%		-22.78%	-57.10%

May. 31	Hunan Jingfeng Pharmaceutical Co.,Ltd. Approves Nomination of Zhang Li as Non-Independent Director	CI
Apr. 29	Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Hunan Jingfeng Pharmaceutical Co.,Ltd. Announces Management Changes

January 27, 2021 at 02:32 pm EST

Hunan Jingfeng Pharmaceutical Co.,Ltd. at the Extraordinary General Meeting held on January 26, 2021 approved Xie Shuqing, Bi Yuan as non-independent directors, Huang Liping, Liu Runhui, Peng Long as independent directors and Teng Xiaoqing, Hu Xiongwen as supervisors.

Latest news about Hunan Jingfeng Pharmaceutical Co.,Ltd.

Hunan Jingfeng Pharmaceutical Co.,Ltd. Approves Nomination of Zhang Li as Non-Independent Director	May. 31	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Jingfeng Pharmaceutical Unit Sells Property for $16.8 Million	22-11-18	MT
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Beijing Zhouyu Energy Technology Co., Ltd. completed the acquisition of a 5% stake in Hunan Jingfeng Pharmaceutical Co.,Ltd. from Ye Xiangwu, Ye Gaojing, and Ye Xianglun.	22-03-02	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Beijing Zhouyu Energy Technology Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Hunan Jingfeng Pharmaceutical Co.,Ltd. from Ye Xiangwu, Ye Gaojing, and Ye Xianglun for approximately CNY 220 million.	21-10-11	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Announces Management Changes	21-01-27	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Hangzhou Fuyue Yize Equity Investment Partnership Enterprise (Limited Partnership) completed the acquisition of a 20% stake in Wisdom Pharmaceutical Co., Ltd. from Hunan Jingfeng Pharmaceutical Co.,Ltd..	20-10-15	CI
Hangzhou Fuyue Yize Equity Investment Partnership Enterprise (Limited Partnership) signed a share transfer agreement to acquire a 20% stake in Wisdom Pharmaceutical Co., Ltd. from Hunan Jingfeng Pharmaceutical Co.,Ltd. for approximately CNY 160 million.	20-09-11	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Hunan Jingfeng Pharmaceutical's Unit Plans to Transfer 43% Stake in Pharmaceutical Firm	20-05-11	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-21	CI

Chart Hunan Jingfeng Pharmaceutical Co.,Ltd.

Duration

Period

Chart Hunan Jingfeng Pharmaceutical Co.,Ltd.

More charts

Company Profile

Hunan Jingfeng Pharmaceutical Co.,Ltd., formerly Hunan Tianyi Science and Technology Co., Ltd, is a China-based company principally engaged in the research, development, manufacture and sale of chemical drugs, biochemical drugs and traditional Chinese patent drugs. The Company's main products includes cardio and cerebrovascular drugs, antihypertensive and hypolipidemic drugs, orthopedic drugs, anti-tumor products, endocrine drugs, digestive system drugs, antiviral drugs and anti-infective drugs, among others. The Company is also involved in commodity import and export trading, business management and consulting, as well as medical technology consulting business. The Company distributes its products in the domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HUNAN JINGFENG PHARMACEUTICAL CO.,LTD.	-57.10%	169M
ELI LILLY AND COMPANY	+45.82%	765B
NOVO NORDISK A/S	+40.95%	632B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
NOVARTIS AG	+11.88%	216B
ROCHE HOLDING AG	-0.78%	219B
AMGEN INC.	+5.90%	164B

Other Pharmaceuticals